TOLL-LIKE RECEPTOR 9 INFLUENCES INFLAMMATORY ARTHRITIS AND OSTEOCLASTOGENESIS

被引:0
|
作者
Fischer, A. [1 ]
Abdollahi-Rodsaz, S. [2 ,3 ]
Yau, A. C. Y. [4 ]
Lonnblom, E. [4 ]
Holmdahl, R. [4 ]
Steiner, G. [1 ]
机构
[1] Med Univ Vienna, Div Rheumtol, Internal Med 3, Vienna, Austria
[2] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, Nijmegen, Netherlands
[3] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY USA
[4] Karolinska Inst, Dept Med Biochem & Biophys, Med Inflammat Res, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P020
引用
收藏
页码:A22 / A22
页数:1
相关论文
共 50 条
  • [41] Toll-like Receptor 9, What O'Clock Is It?
    Obermann, Hannah-Lena
    Bauer, Stefan
    IMMUNITY, 2012, 36 (02) : 159 - 161
  • [42] A Novel Toll-Like Receptor 9 Signaling in Cardiomyocytes
    Shintani, Yasunori
    Kapoor, Amar
    Drexler, Hannes
    Terracciano, Cesare
    Smolenski, Ryszard
    Kaneko, Masahiro
    Harada, Narumi
    Coppen, Steven
    Narita, Takuya
    Campbell, Niall
    Ikebe, Chiho
    Thiemermann, Chris
    Yashiro, Kenta
    Suzuki, Ken
    CIRCULATION, 2011, 124 (21)
  • [43] Toll-like receptor 9 regulates tumor necrosis factor-α expression by different mechanisms -: Implications for osteoclastogenesis
    Amcheslavsky, A
    Zou, W
    Bar-Shavit, Z
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (52) : 54039 - 54045
  • [44] ANTAGONIZING ENDOSOMAL TOLL-LIKE RECEPTORS DIMINISHES INFLAMMATORY ARTHRITIS
    Herman, S.
    Fischer, A.
    Hoffmann, M.
    Steiner, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 317 - 318
  • [45] γ-Glutamyltranspeptidase is an endogenous activator of Toll-like receptor 4-mediated osteoclastogenesis
    Moriwaki, Sawako
    Into, Takeshi
    Suzuki, Keiko
    Miyauchi, Mutsumi
    Takata, Takashi
    Shibayama, Keigo
    Niida, Shumpei
    SCIENTIFIC REPORTS, 2016, 6
  • [46] Toll-like receptor 4 deficiency affects the balance of osteoclastogenesis and osteoblastogenesis in periodontitis
    Pan, Lu
    She, He
    Hu, Yong
    Liu, Laikui
    Wang, Hongyan
    Zhu, Lifang
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 137
  • [47] Regulation and function of toll-like receptor 9 in macrophages
    Sweet, Matthew J.
    Schroder, Kate
    Sester, David P.
    Trieu, Angela
    Rehli, Michael
    Risvanathan, Kumar
    Stacey, Katryn J.
    Hume, David A.
    INFLAMMATION RESEARCH, 2005, 54 : S186 - S186
  • [48] Therapeutic potential of Toll-like receptor 9 activation
    Krieg, Arthur M.
    NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (06) : 471 - 484
  • [49] Toll-like receptor 9 agonists as cancer therapeutics
    Holtick, Udo
    Scheulen, Max E.
    von Bergwelt-Baildon, Michael S.
    Weihrauch, Martin R.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2011, 20 (03) : 361 - 372
  • [50] TOLL-LIKE RECEPTOR 9 IN TRAUMA-HEMORRHAGE
    Zhang, X.
    Gao, M.
    Yu, H.
    Lu, C.
    Ha, T.
    Williams, D. L.
    Li, C.
    Kao, R.
    SHOCK, 2011, 35 : 41 - 41